March 22, 2024Cancer Research

Chimeric Cytokine Receptors Enhance Expansion and Efficacy of CAR-T Cell Therapies

View Full Paper

Ask AI

Bookmark

Chimeric cytokine receptors improve expansion, memory phenotype, and tumor cell killing in engineered CAR-T cell therapies targeting human multiple myeloma.
IL-7Rα-containing constructs increase CD8+ CAR-T cell numbers in blood, spleen, and bone marrow while sustaining long-term anti-tumor activity in vivo.
In vitro and mouse model evaluations show small-molecule activated chimeric cytokine receptors enhance ide-cel and cilta-cel efficacy; mouse model limits apply.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Preclinical study demonstrates that chimeric cytokine receptors enhance CAR-T cell expansion and tumor control in multiple myeloma models, highlighting targeted immunotherapy control.

Cite This Study

Newcomb et al. (2024) studied this question.

synapsesocial.com/papers/68e72ce8b6db6435876a7028 https://doi.org/10.1158/1538-7445.am2024-3609

View Full Paper

Ask AI

Bookmark

Implication

Preclinical study demonstrates that chimeric cytokine receptors enhance CAR-T cell expansion and tumor control in multiple myeloma models, highlighting targeted immunotherapy control.

Chimeric Cytokine Receptors Enhance Expansion and Efficacy of CAR-T Cell Therapies

Key Points

Discussion

Implication

Cite This Study

Chimeric Cytokine Receptors Enhance Expansion and Efficacy of CAR-T Cell Therapies

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider